Epimorphin promotes human hepatocellular carcinoma invasion and metastasis through activation of focal adhesion kinase/extracellular signal-regulated kinase/matrix metalloproteinase-9 axis

Hepatology

Volumn 54, Issue 5, 2011, Pages 1808-1818

  Jia, Ya Li ^a   Shi, Lei ^a,b   Zhou, Jun Nian ^a   Fu, Chun Jiang ^a   Chen, Lin ^a   Yuan, Hong Feng ^a   Wang, Yun Fang ^a   Yan, Xin Long ^a   Xu, Ying Chen ^a   Zeng, Quan ^a   Yue, Wen ^a   Pei, Xue Tao ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b BEIJING 302 HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FOCAL ADHESION KINASE; GELATINASE B; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SYNTAXIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INVASION; CELL STRAIN HEPG2; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE SILENCING; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; LIVER METASTASIS; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION;

CARCINOMA, HEPATOCELLULAR; CELL DIVISION; CELL MOVEMENT; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FOCAL ADHESION KINASE 1; HEP G2 CELLS; HEPATIC STELLATE CELLS; HUMANS; LIVER; LIVER NEOPLASMS; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; SYNTAXIN 1;

EID: 80055063430     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.24562     Document Type: Article

References (39)

1. Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 2006; 6: 674-687.
2. El-Serag HB. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 2004; 127: S27-S34.
3. Albini A, Sporn MB. The tumour microenvironment as a target for chemoprevention. Nat Rev Cancer 2007; 7: 139-147.
4. Orimo A, Weinberg RA. Stromal fibroblasts in cancer-a novel tumor-promoting cell type. Cell Cycle 2006; 5: 1597-1601.
5. Hu M, Polyak K. Microenvironmental regulation of cancer development. Curr Opin Genet Dev 2008; 18: 27-34.
6. Yan XL, Fu CJ, Chen L, Qin JH, Zeng Q, Yuan HF, et al. Mesenchymal stem cells from primary breast cancer tissue promote cancer proliferation and enhance mammosphere formation partially via EGF/EGFR/Akt pathway. Breast Cancer Res Treat 2011 May 17. PubMed PMID: 21584665.
7. Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000; 275: 2247-2250.
8. Dubuisson L, Lepreux S, Bioulac-Sage P, Balabaud C, Costa AMA, Rosenbaum J, Desmouliere A. Expression and cellular localization of fibrillin-1 in normal and pathological human liver. J Hepatol 2001; 34: 514-522.
9. Radisky DC, Hirai Y, Bissell MJ. Delivering the message: epimorphin and mammary epithelial morphogenesis. Trends Cell Biol 2003; 13: 426-434.
10. Hirose M, Watanabe S, Oide H, Kitamura T, Miyazaki A, Sato N. New function of Ito cells in liver morphogenesis: evidence using a novel morphogenic protein, epimorphin, in vitro. Biochem Biophys Res Commun 1996; 225: 155-160.
11. Watanabe S, Hirose M, Wang XE, Ikejima K, Oide H, Kitamura T, et al. A novel hepatic stellate (Ito) cell-derived protein, epimorphin, plays a key role in the late stages of liver regeneration. Biochem Biophys Res Commun 1998; 250: 486-490.
12. Miura K, Yoshino R, Hirai Y, Goto T, Ohshima S, Mikami KI, et al. Epimorphin, a morphogenic protein, induces proteases in rodent hepatocytes through NF-kB. J Hepatol 2007; 47: 834-843.
13. Miura K, Nagai H, Ueno Y, Goto T, Mikami K, Nakane K, et al. Epimorphin is involved in differentiation of rat hepatic stem-like cells through cell-cell contact. Biochem Biophys Res Commun 2003; 311: 415-423.
14. Wang Y, Wang LH, Iordanov H, Swietlicki EA, Zheng Q, Jiang SJ, et al. Epimorphin(-/-) mice have increased intestinal growth, decreased susceptibility to dextran sodium sulfate colitis, and impaired spermatogenesis. J Clin Invest 2006; 116: 1535-1546.
15. Zhou JN, Zhao L, Qin LP, Wang J, Jia YL, Yao HL, et al. Epimorphin Regulates bile duct formation via effects on mitosis orientation in rat liver epithelial stem-like cells. Plos One 2010; 5: e9732.
16. Jia Y, Yao H, Zhou J, Chen L, Zeng Q, Yuan H, et al. Role of epimorphin in bile duct formation of rat liver epithelial stem-like cells: involvement of small G protein RhoA and C/EBPbeta. J Cell Physiol 2010 Dec 30. PubMed PMID: 21194116.
17. Bascom JL, Fata JE, Hirai Y, Sternlicht MD, Bissell MJ. Epimorphin overexpression in the mouse mammary gland promotes alveolar hyperplasia and mammary adenocarcinoma. Cancer Res 2005; 65: 8617-8621.
18. Shaker A, Swietlicki EA, Wang LH, Jiang SJ, Onal B, Bala S, et al. Epimorphin deletion protects mice from inflammation-induced colon carcinogenesis and alters stem cell niche myofibroblast secretion. J Clin Invest 2010; 120: 2081-2093.
19. Tilghman RW, Slack-Davis JK, Sergina N, Martin KH, Iwanicki M, Hershey ED, et al. Focal adhesion kinase is required for the spatial organization of the leading edge in migrating cells. J Cell Sci 2005; 118: 2613-2623.
20. Yue W, Dacic S, Sun Q, Landreneau R, Guo MZ, Zhou W, et al. Frequent inactivation of RAMP2, EFEMP1 and Dutt1 in lung cancer by promoter hypermethylation. Clin Cancer Res 2007; 13: 4336-4344.
21. Yue W, Sun QH, Landreneau R, Wu CY, Siegfried JM, Yu J, Zhang L. Fibulin-5 suppresses lung cancer invasion by inhibiting matrix metalloproteinase-7 expression. Cancer Res 2009; 69: 6339-6346.
22. Zhang P, Cong B, Yuan HF, Chen L, Lv Y, Bai CX, et al. Overexpression of spindlin1 induces metaphase arrest and chromosomal instability. J Cell Physiol 2008; 217: 400-408.
23. Ohashi Y, Tsuchiya Y, Koizumi K, Sakurai H, Saiki I. Prevention of intrahepatic metastasis by curcumin in an orthotopic implantation model. Oncology 2003; 65: 250-258.
24. Amann T, Bataille F, Spruss T, Muhlbauer M, Gabele E, Scholmerich J, et al. Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma. Cancer Sci 2009; 100: 646-653.
25. Yang JD, Nakamura I, Roberts LR. The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets. Semin Cancer Biol 2011; 21: 35-43.
26. Zhang LY, Ishikawa O, Takeuchi Y, Miyachi Y. Immunohistochemical distribution of epimorphin in human and mouse tissues. Histochem J 1998; 30: 903-908.
27. Li Y, Tang ZY, Ye SL, Liu YK, Chen J, Xue Q, et al. Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97. World J Gastroenterol 2001; 7: 630-636.
28. Hirai Y, Nelson CM, Yamazaki K, Takebe K, Przybylo J, Madden B, Radisky DC. Non-classical export of epimorphin and its adhesion to alpha v-integrin in regulation of epithelial morphogenesis. J Cell Sci 2007; 120: 2032-2043.
29. Ma L, Young J, Prabhala H, Pan E, Mestdagh P, Muth D, et al. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol 2010; 12: 247-256.
30. Joyce JA, Pollard JW. Microenvironmental regulation of metastasis. Nat Rev Cancer 2009; 9: 239-252.
31. Atzori L, Poli G, Perra A. Hepatic stellate cell: a star cell in the liver. Int J Biochem Cell Biol 2009; 41: 1639-1642.
32. Herrmann J, Gressner AM, Weiskirchen R. Immortal hepatic stellate cell lines: useful tools to study hepatic stellate cell biology and function? J Cell Mol Med 2007; 11: 704-722.
33. Ooi LPJ, Crawford DHG, Gotley DC, Clouston AD, Strong RW, Gobe GC, et al. Evidence that "myofibroblast-like" cells are the cellular source of capsular collagen in hepatocellular carcinoma. J Hepatol 1997; 26: 798-807.
34. Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 2008; 88: 125-172.
35. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002; 2: 161-174.
36. Chung TW, Moon SK, Chang YC, Ko JH, Lee YC, Cho G, et al. Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism. FASEB J 2004; 18: 1670-1681.
37. Yao HL, Jia YL, Zhou JN, Wang J, Li YH, Wang YF, et al. RhoA promotes differentiation of WB-F344 cells into the biliary lineage. Differentiation 2009; 77: 154-161.
38. Mitra SK, Schlaepfer DD. Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr Opin Cell Biol 2006; 18: 516-523.
39. Moreno-Bueno G, Peinado H, Molina P, Olmeda D, Cubillo E, Santos V, et al. The morphological and molecular features of the epithelial-to-mesenchymal transition. Nat Protoc 2009; 4: 1591-1613.